Half-year report · Q2
3154.TEDINET S100V7O6
Period2024-07-01 → 2024-12-31
Filed2025-02-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥142.7bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥259.8bn | 2023-07-01 → 2024-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥126.7bn | 2023-07-01 → 2023-12-31 | Cons. | Net sales |
| Operating income | ¥751m | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥681m | 2023-07-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥983m | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.8bn | 2023-07-01 → 2024-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥900m | 2023-07-01 → 2023-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥983m | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥895m | 2023-07-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥407m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥505m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥407m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥505m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥119.8bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥114.8bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥112.6bn | at 2023-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥99.8bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥95.1bn | at 2024-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥20.0bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥19.7bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥18.6bn | at 2023-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.0bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥13.6bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥14.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.5bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.3bn | at 2023-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.9bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.5bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.4bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.7bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥586m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥4.0bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.7bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥18.32 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥51.21 | 2023-07-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.03 | 2023-07-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥18.32 | 2024-07-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥51 | 2023-07-01 → 2024-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.93 | 2023-07-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 16.7% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.2% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 16.5% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥4.5bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥139.7bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥139.7bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥9m |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥5.0bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥3.0bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥3.0bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥250m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥142.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥142.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥5.3bn |
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-12-31 | −¥7m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-12-31 | −¥7m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-12-31 | −¥4.2bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥123.8bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥123.8bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥7m |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥4.6bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥2.9bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥2.9bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥201m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2023-12-31 | ¥126.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2023-12-31 | ¥126.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥7m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2023-12-31 | ¥4.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 558
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase decrease in provision for directors bonuses ope cf | Prior1YTDDuration | -98004000 | JPY |
| Increase decrease in provision for directors bonuses ope cf | CurrentYTDDuration | -58236000 | JPY |
| Increase decrease in provision for share based compensation ope cf | Prior1YTDDuration | 6736000 | JPY |
| Increase decrease in provision for share based compensation ope cf | CurrentYTDDuration | -78085000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -19123000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -21521000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 45979000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 74902000 | JPY |
| Stock issuance cost ope cf | Prior1YTDDuration | - | JPY |
| Stock issuance cost ope cf | CurrentYTDDuration | 359000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | Prior1YTDDuration | -3027000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | CurrentYTDDuration | -1878000 | JPY |
| Loss on retirement of noncurrent assets ope cf | Prior1YTDDuration | 2658000 | JPY |
| Loss on retirement of noncurrent assets ope cf | CurrentYTDDuration | 1860000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YTDDuration | 12083000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYTDDuration | - | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -9860697000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -5596529000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -1060922000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -855708000 | JPY |
| Decrease increase in lease investment assets ope cf | Prior1YTDDuration | 25401000 | JPY |
| Decrease increase in lease investment assets ope cf | CurrentYTDDuration | 17304000 | JPY |
| Decrease increase in other current assets ope cf | Prior1YTDDuration | -541820000 | JPY |
| Decrease increase in other current assets ope cf | CurrentYTDDuration | -510383000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 8573303000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 3456470000 | JPY |
| Increase decrease in provision for loss on guarantees ope cf | Prior1YTDDuration | 3228000 | JPY |
| Increase decrease in provision for loss on guarantees ope cf | CurrentYTDDuration | -270000 | JPY |
| Subsidy income ope cf | Prior1YTDDuration | - | JPY |
| Subsidy income ope cf | CurrentYTDDuration | -89105000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | Prior1YTDDuration | -728898000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | CurrentYTDDuration | 149506000 | JPY |
| Increase decrease in other current liabilities ope cf | Prior1YTDDuration | -8262000 | JPY |
| Increase decrease in other current liabilities ope cf | CurrentYTDDuration | -46906000 | JPY |
| Other net ope cf | Prior1YTDDuration | 28195000 | JPY |
| Other net ope cf | CurrentYTDDuration | 50673000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | -1838803000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | -1425244000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 18968000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 23564000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -46882000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -74897000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -435578000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -536911000 | JPY |
| Income taxes refund ope cf | Prior1YTDDuration | 799488000 | JPY |
| Income taxes refund ope cf | CurrentYTDDuration | 190699000 | JPY |
| Payments for directors retirement benefits ope cf | Prior1YTDDuration | - | JPY |
| Payments for directors retirement benefits ope cf | CurrentYTDDuration | -2000000 | JPY |
| Proceeds from subsidy ope cf | Prior1YTDDuration | - | JPY |
| Proceeds from subsidy ope cf | CurrentYTDDuration | 3307093000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |